Mostrando 10 resultados de: 14
Filtros aplicados
Publisher
Revista Latinoamericana de Hipertension(7)
Current Pharmaceutical Design(3)
American Journal of Therapeutics(2)
Vessel Plus(2)
Área temáticas
Enfermedades(12)
Farmacología y terapéutica(6)
Fisiología humana(4)
Bioquímica(3)
Medicina y salud(3)
Área de conocimiento
Enfermedad cardiovascular(6)
Medicina interna(4)
Bioquímica(3)
Genética(3)
Inmunología(2)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(14)
ODS 17: Alianzas para lograr los objetivos(10)
ODS 2: Hambre cero(7)
ODS 10: Reducción de las desigualdades(5)
ODS 12: Producción y consumo responsables(4)
Origen
scopus(14)
Cigarette smoking and cardiovascular disease
ReviewAbstract: Cigarette smoking is considered a risk factor for many diseases especially for cardiovascular diseasPalabras claves:Cardiovascular disease, risk factor, smokingAutores:Aguirre M.A., Aparicio D., Bustamante M., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Urdaneta A., Valmore Bermúdez, Velasco M.Fuentes:scopusAssociation between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in maracaibo, Zulia State, Venezuela
ArticleAbstract: Apoliprotein (Apo) E gene polymorphisms have been associated with high plasma lipids levels and cardPalabras claves:ApoE, Cardiovascular disease, hypercholesterolemia, Lipids profile, polymorphismsAutores:Arráiz N., Carem Prieto, Escalona C., Reyes F., Rondón N., Sánchez M.P., Sanz E., Valmore Bermúdez, Velasco M.Fuentes:scopusAbnormally high lipoprotein(a) levels in African-American communities from venezuela faced to other african-descending populations: Are ethnic origins related?
ArticleAbstract: Objective. Lipoprotein(a) is an independent risk factor for coronary artery disease. In Venezuela, LPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Arráiz N., Cano-Ponce C., Ciszek A., Faria J., Gotera D., Guerra-Torres X.E., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusInfection, inflammation and atherosclerotic vascular disease
ReviewAbstract: Cardiovascular disease (CVD) is the leading cause of death in developed countries. The causes of thiPalabras claves:atherosclerosis, Cardiovascular disease, Chlamydia, infection, inflammation, risk factorAutores:Aparicio D., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Martínez Y., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusEpidemiological behavior of high -sensitivity C-Reactive Protein (hs-CRP) in adult individuals in the Maracaibo city, Venezuela
ArticleAbstract: Objectives: High-sensitivity C-Reactive Protein (hs-CRP) is one of the most applied inflammation marPalabras claves:C-Reactive protein, Cardiovascular disease, Low-grade inflammation, Metabolic syndrome, RISK FACTORSAutores:Aguirre M.A., Añez-Ramos R., Apruzzese V., Bello L.M., Cabrera M., Chávez-Castillo M., Fuenmayor D., González M.C., Marcano R.P., Martínez M.S., Mendoza L., Montiel M., Nava A., Pachano F., Rincón T., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Torres Y., Valmore Bermúdez, Velasco M., Villalobos M.Fuentes:scopusUnusually elevated levels of lipoprotein(a) in Afro-American populations from south of Lake Maracaibo
ArticleAbstract: Objective. Lipoproteína(a), [Lp(a)], is an independent risk factor for coronary artery disease. In VPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Linares S., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusOmega-3 polyunsaturated fatty acids and cardiovascular health: a molecular view into structure and function
ReviewAbstract: Given the notorious impact of cardiovascular disease (CVD) as the current leading cause of mortalityPalabras claves:Cardiovascular disease, Docosahexaeonic acid, Eicosapentaenoic acid, Omega-3 polyunsaturated fatty acidsAutores:Calvo M.J., Chávez-Castillo M., Luzardo E., Martínez M.S., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Velasco M., Villasmil N.Fuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusPrevalence of different lipid profile abnormalities in the consultation of cardiovascular risk factors from the "Dr. Félix Gómez" Endocrine and Metabolic Diseases Research Center in the period from January 2006 to January 2007
ArticleAbstract: Objective: Isolated (or mixed with other dyslipidemias) low HDLc levels are risk factors for coronarPalabras claves:Cardiovascular disease, dyslipidemia, Low isolated HDLc, PREVALENCEAutores:Cano-Ponce C., Luti Y., Mengual-Moreno E., Sánchez D., Scott G., Valmore Bermúdez, Velasco M.Fuentes:scopus